William Guyer, Chief Development Officer at CORCEPT THERAPEUTICS INC (CORT), sold 40,000 shares at $70.85 ($2.8M) on 2025-09-02, disclosed to the SEC on 2025-09-04.
Scheduled sale ($2.8M) by Chief Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $70.39 | 15,594 | $1.1M | 38.9% |
| 2 | $70.39 | 15,594 | $1.1M | 38.9% |
| 3 | $70.85 | 4,406 | $312K | 11.1% |
| 4 | $70.85 | 4,406 | $312K | 11.1% |
| Total | $70.49 avg | 40,000 | $2.8M | 100% |
| Filing → |
| CORT | SELL | 2026-06-04 | $1.4M | — | Filing → |
| CORT | SELL | 2026-05-07 | $1.0M | — | Filing → |
| CORT | SELL | 2026-04-08 | $819K | — | Filing → |